Why Trust is the Missing Ingredient in Medical Research
For decades, the world of medical research has faced a quiet but massive problem: most clinical trials don't look like the real world. While science moves faster than ever, the way we find people to participate in life-saving studies is stuck in the past. This is especially true for underrepresented communities—including Black, Hispanic, and Asian Americans—who are often left out of the very research that could save their lives.
At Glassbury AI, we believe that medical progress shouldn't be a "black box". We are building a trust-centric marketplace designed to make clinical trials faster, cheaper, and radically more equitable.
The Heart of the Problem
The numbers are staggering. Two-thirds of clinical trials fail to meet their enrollment targets, costing the healthcare industry approximately $40 billion every year. Even worse is the "diversity gap": underrepresented groups make up 37% of the U.S. population but less than 5% of participants in Alzheimer’s trials. This happens even though these communities often face a 2x higher risk for the disease.
Traditional recruitment relies on stale databases and cold outreach. It ignores the deep-rooted medical mistrust and logistical barriers that keep people from signing up.
Introducing the 'Trust Flywheel'
Glassbury AI doesn't start with data; we start with people. We use what we call a Trust Flywheel to bridge the gap between researchers and the community.
Community First: Instead of sending random emails, we partner with local, trusted organizations like the Northside Ministerial Alliance and Second Missionary Baptist Church.
Education and Awareness: We co-host Alzheimer’s Awareness Workshops in neighborhoods where they are needed most. These sessions aren't just about recruitment; they focus on education and validating historical concerns before ever asking for trial participation.
Building a Pipeline: These workshops turn into a natural recruitment pipeline where trust is the foundation, not an afterthought.
Smart Technology That Puts Patients First
Once trust is established, our advanced AI takes over to make the journey as smooth as possible.
Better Matching with SYCQ 1.0
Finding the right trial can feel like finding a needle in a haystack. Our SYCQ 1.0 platform uses "Agentic AI" to scan complex medical records and match patients to the right trials with incredible precision, reducing the number of people who get rejected during the screening process.
Reducing the Dropout Rate
The clinical research industry suffers from a 23% trial dropout rate. Life gets in the way, and medical jargon can be overwhelming. Glassbury AI is fighting this with a 24/7 AI Virtual Advocate. This "companion in your pocket" translates complex legal and medical terms into plain language and uses gentle reminders—called "nudges"—to help patients stay motivated and engaged.
A Fairer Future for Medicine
Glassbury AI is more than just a tech company; we are on a mission to transform health equity. By combining the human touch of community partnerships with the power of Google’s multimodal AI, we are ensuring that the future of medicine belongs to everyone.
When we build with the community rather than just for them, everyone wins. We get better data, faster treatments, and—most importantly—a healthcare system that truly represents us all.
